Ungsedhapand, Chaiwat <br/><br/>
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Jun 2004 
 - 693-701 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/00126334-200406010-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>CD4 Lymphocyte Count<br/>Didanosine--administration & dosage<br/>Dideoxynucleosides--administration & dosage<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Lamivudine--administration & dosage<br/>Male<br/>RNA, Viral--blood<br/>Retrospective Studies<br/>Stavudine--administration & dosage<br/>Thailand<br/>Time Factors<br/>Zidovudine--administration & dosage